NANOVIRICIDES, INC. — Director's Dealing 2014

Jul 19, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NANOVIRICIDES, INC. (NNVC)
CIK: 0001379006
Period of Report: 2014-07-02

Reporting Person: BONIUK MILTON (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-07-17	Common Stock, par value $0.001	P	28572	$3.50	Acquired	658963	Direct
2014-07-17	Common Stock, par value $0.001	P	28572	$3.50	Acquired	314286	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-07-02	10% Coupon Series C Convertible Debenture	$5.25	A	1	Acquired		Common Stock (952381)	Indirect
2014-07-11	Series A Convertible Preferred Stock	$0	A	187000	Acquired		Common Stock (654500)	Indirect

Footnotes

F1: The shares of common stock were acquired upon exercise of warrants issued to the Reporting Person on September 11, 2013.

F2: Held by the Reporting Person and his wife Laurie Boniuk.

F3: Does not include warrants to purchase an additional 542,856 shares of common stock, 314,286 shares of common stock held in the name of Boniuk Interests, Ltd., warrants to purchase an additional 257,142 shares of common stock held in the name of Boniuk Interests, Ltd., 190,477 shares of common stock held by Boniuk Charitable Foundation, 100 shares of common stock issuable upon exercise of warrants that are currently exercisable, an indeterminate number of shares of common stock issuable upon conversion of debentures held by Boniuk Interests Ltd. and Boniuk Charitable Foundation that are currently exercisable, 952,381 shares of common stock issuable upon conversion of a debenture and 654,500 shares of common stock underlying shares of Series A Preferred Stock which are not readily exercisable held by Milton Boniuk IRA.

F4: See Note 3 regarding the explanation of the Reporting Person's other holdings of the Issuer's securities

F5: The securities are presently exercisable.

F6: The derivative securities do not expire.